Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mission Bio Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by a single distinct examiner, SALMON, KATHERINE D, who is the busiest examiner for the portfolio. The portfolio is currently limited to a single distinct art unit, indicating a specific technical focus for the company's pending patent application. This centralization simplifies the administrative burden of tracking the application's progress through the patent office.
The busiest examiner pending count of 1 confirms that SALMON, KATHERINE D is the sole examiner responsible for the company's current pending workload. This examiner's perspective on the biotechnology and pharmaceutical claims will be the deciding factor for the application's success. With only a single distinct examiner and art unit, the company can focus its legal strategy on the specific preferences and prior art interpretations of a single individual. This prosecution profile suggests a very targeted entry into the biotechnology patent landscape.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 1 | 42.8% | +37.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18535441 | METHOD, SYSTEM, AND APPARATUS FOR ANALYZING AN ANALYTE OF A SINGLE CELL | SALMON, KATHERINE D | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18535441 | METHOD, SYSTEM, AND APPARATUS FOR ANALYZING AN ANALYTE OF A SINGLE CELL | SALMON, KATHERINE D | 1682 | §102§103§112DP | Non-Final OA | — | Pending | Dec 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial